Invited Commentary
Commentary on “Reasons for Chemotherapy Refusal or Acceptance in Older Adults with Cancer”
Abstract
Much attention is placed on documenting and, one hopes, obtaining, informed decisions in medical settings. We answer questions and sign forms requesting permission for things as varied as sharing personal health information, receiving annual flu shots, and undergoing aneurism repair. Institutional review boards, the organizations tasked with protecting research patients’ safety, take this process seriously and actively evaluate documentation for clarity (eg, presence of medical jargon), completeness (eg, potential adverse effects), and transparency (eg, is anyone getting paid, and by whom?).This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
Reference1. Gopal N, Kozikowski A, Barginear MF, et al. Reasons for chemotherapy refusal or acceptance in older adults with cancer. South Med J 2017;110:47-53.
